Follow the journey of this football coach who received the first liver transplant for metastatic colon cancer ever performed ...
13d
Agenus AGM: Bot/Bal Combo Targets “Cold” MSS Colorectal Cancer as Phase III BATMAN Trial Launches
Agenus (NASDAQ:AGEN) used its March stakeholder webcast to highlight progress for its investigational immunotherapy ...
Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study. Efficacy and safety of ...
TAS-102 plus bevacizumab in refractory metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials with validation from prospective single-arm studies. This is an ASCO ...
September 27, 2012 — The US Food and Drug Administration (FDA) has approved the oral therapy regorafenib (Stivarga, Bayer) for the treatment of metastatic colorectal cancer. Regorafenib is a novel ...
SurvivorNet on MSN
Colon cancer is not one disease: Why BRAF & KRAS mutations matter
Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results